Seed funding

Friday, January 24, 2020 | 6 months ago
Luxia Scientific, the french biotech that launched "1test1", the first CE marked diagnostics of loss of bacterial diversity of the human gut, announced today that it has raised close to 700 000  €.
Press release (in french)